Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - BIOVEST INTERNATIONAL INC | d366662d8k.htm |
| EX-99.1 - PRESS RELEASE - BIOVEST INTERNATIONAL INC | d366662dex991.htm |
 BiovaxID MCL Study: Overall Survival
MCL Overall Survival (1996-2004)
BiovaxID Phase 2 MCL Study
Hermann A, et al. J Clin Oncol. 2009 Feb;27:511
Figure 1
Exhibit 99.2 |
 BiovaxID MCL Study: OS: Id-Specific GM-CSF (<> median)
Figure 2 |
 Time-to-Next-Treatment: Id-Specific GM-CSF (<>
median) Figure 3 |